This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages)
|
Evogene is a computational biology company based in Israel. Evogene Ltd. (NASDAQ:EVGN) has developed a unique computational predictive biology "CPB" platform, which leverages big data with advanced algorithms such as machine learning and other artificial intelligence (AI), while adding a deep understanding of biology and advanced biological technologies. Evogene is using its proprietary CPB platform to computationally design and develop next-generation life-science products based upon three core components: microbes, small molecules, and genetic elements.
 | |
| Company type | Public |
|---|---|
| TASE: EVGN NYSE: EVGN | |
| Industry | Computational Biology |
| Founded | 2002 |
| Founder | Dr. Hagai Karchi and Dr. Rafi Meissner |
| Headquarters | Rehovot, Israel |
Key people | Sarit Firon, Chairperson of Board, Ofer Haviv, President & CEO |
| Subsidiaries | Biomica, Canonic, Lavie Bio, AgPlenus, Castera |
| Website | www |
Evogene's computational platform allows it to substantially increase the probability of successful life-science product development, increase the efficiency and reduce the toxicity of its life-science products while reducing time and cost to development. Its strategic partners include BASF (OTCQX:BASFY), Bayer (OTCPK:BAYZF), Corteva (CTVA), ICL Group Ltd. (ICL) as well as various academic and medical institutions.
References
edit
 | This article about a corporation or company specializing in health technology is a stub. You can help Wikipedia by expanding it. |
  | This article about an Israeli company is a stub. You can help Wikipedia by expanding it. |